Guiscafré-Gallardo H

Language: Spanish
References: 27
Page: 249-260
PDF size: 569.28 Kb.

ABSTRACT

Even though most of the acute respiratory infections (ARI) are self-limited, the mistakes in diagnosis are a well-known problem. On one hand, an excessive use of antimicrobials (90% of the cases) and symptomatic medicines (98% of the cases) has been demonstrated. On the other hand, pneumonia, the main complication of ARI, is not diagnosed or treated on time mainly in children younger than 5 years old, leading to a higher mortality rate. The deaths analyzed -through the verbal autopsy technique- have allowed us to identify that 70% of the children with pneumonia, younger than 5 years old, die at home, and moreover, 60% of those children die only a few hours after they have been examined by a doctor.
Due to this problem, we present to the readers of this journal a series of 3 clinical guides that have been previously validated for the Mexican population with governmental health care, adapting these guides to the first level of institutional or private health care for people not included in any health care system. The first guide is to facilitate the diagnosis of each ARI disease. The other 2 are to be able to provide the necessary complete treatment of ARI in each clinical entity, which are now grouped on the basis of their etiology and the therapy that is necessary. The second guide is therefore related to the treatment of the cases without tachypnoea, this is, without respiratory insufficiency. The management of the first level of health care provided to patients with tachypnoea or with respiratory insufficiency is shown in the third guide. In these 2 treatment guides, the 6 components of the integral and complete medical care of children are included, as it is described in the text and in table 2. The more controversial and relevant aspects are commented in each clinical guide.
Finally, pediatricians and medical readers are challenged to “Compare your clinical guides with your daily practice and act accordingly!” Several reflections about the excellence of pediatric consultations are also presented.

REFERENCES

1. OPS. El control de las infecciones respiratorias agudas en los sistemas locales de salud. Washington, DC, USA: Organización Panamericana de la Salud, OPS/HCP/ARI/95.05; 1995.

2. Tapia DA, Álvarez LC, García CJA, Velázquez MO. Morbilidad por causas seleccionadas en población menor de cinco años. México 1980-1993. En: La salud de los niños, cifras nacionales. México: UNICEF; 1994. p. 99-108.

3. Secretaría de Salud. México. Infecciones respiratorias agudas. Bol Epidemiol Sistema Único Inform. 2006; 52: 12.

4. Flores SH, Reyes HM, Pérez-Cuevas R, Guiscafré HG. The day care center as a risk factor for acute respiratory infections. Arch Med Res. 1999; 30: 216-23.

5. Pérez-Cuevas R, Muñoz O, Guiscafré H, Reyes H, Tomé P, Gutiérrez G. Patrones de prescripción terapéutica en infección respiratoria aguda y diarrea aguda en dos instituciones de salud (IMSS y SSA). IV. Características de la prescripción médica. Gac Med Mex. 1992; 128: 543-8.

6. Reyes H, Guiscafré H, Muñoz O, Pérez-Cuevas R, Martínez H, Gutiérrez G. Antibiotic noncompliance and Waste in upper respiratory infections and acute diarrhea. J Clin Epidemiol. 1997; 50: 12997-3004.

7. Marrie T. State of art and clinical article. Community acquired pneumonia. Clin Infect Dis. 1994; 18: 501-13.

8. Pérez-Cuevas R, Guiscafré H, Muñoz O, Reyes H, Tomé P, Libreros V, et al. Improving physicians prescribing patterns to treat rhinopharingitis intervention strategies in two health systems of Mexico. Soc Sci Med. 1996; 42: 1185-94.

9. Turrubiates N, Reyes H, Fernández S, Gutiérrez G. Mortalidad por causas seleccionadas de enfermedades infecciosas y crónicas no transmisibles, 1991-2004. Rev Med Inst Mex Seguro Soc. 2006; 44: 5111-9.

10. Villa S, Guiscafré H, Martínez H, Urban JC, Reyes S, Lezana MA, et al. Muertes en el hogar en niños con diarrea o infección respiratoria aguda después de haber recibido atención médica. Bol Med Hosp Infant Mex. 1994; 51: 233-42.

11. Bojalil R, Guiscafré H, Espinosa P, Martínez H, Palafox M, Romero G, et al. The quality of private and public primary health care management of children with diarrhoea and acute respiratory infections in Tlaxcala, Mexico. Health Policy Plan. 1998; 13: 323-31.

12. Reyes H, Tomé P, Guiscafré H, Martínez H. Autopsia verbal en niños con infección respiratoria. Análisis del proceso enfermedad-atención-muerte. Bol Med Hosp Infant Mex. 1993; 50: 7-16.

13. Pio A. WHO Programme on acute respiratory infections. Indian J Pediatr. 1988; 55: 197-205.

14. WHO. Bases técnicas para las recomendaciones de la OPS/OMS sobre el tratamiento de la neumonía en niños en el primer nivel de atención. Ginebra: Organización Mundial de la Salud WHO/ARI/91|.20/OPS/HCP/HCT/ARI/92.1; 1992.

15. Field MJ, Lohr KN. Clinical practice guidelines. Directions for a new agency. En: Field MJ, Lohr KN, editores. Institute of Medicine. Washington, DC: National Academy Press; 2004.

16. Flores-Hernández S, Trejo-y Pérez JA, Reyes H, Pérez-Cuevas R, Loera-Romo G, Juárez N, et al. Diseño y aplicabilidad de una Guía clínica para la atención apropiada en las infecciones respiratorias agudas. Gac Med Mex. 1999; 135: 121-37.

17. Harare M, Shann F. Clinical signs of pneumonia in children. Lancet. 1991; 338: 928-30.

18. Palafox M, Guiscafré H, Reyes H, Muñoz O, Martínez H. Diagnostic value of tachypnoea in pneumonia defined radiologically. Arch Dis Child. 2000; 82: 41-5.

19. Reyes H, Pérez-Cuevas R, Salmerón J, Tomé P, Guiscafré H, Gutiérrez G. Infant mortality due to acute respiratory infections: the influence of primary care processes. Health Policy Plan. 1997; 12: 214-23.

20. Gutiérrez G, Guiscafré H, Verver H, Valdéz J, Rivas E, Loyo E, et al. Programa de atención a la salud del niño en México. Evaluación de la calidad de la atención integrada que se otorga en los centros de capacitación. Gac Med Mex. 2001; 137: 21-30.

21. Gutiérrez G, Flores-Huerta S, Fernández-Garate I, Martínez-Montañez O, Velasco-Murillo V, Fernández-Cantón S, et al. Estrategia de prestación y evaluación de servicios preventivos. Anexo 3, Programa de Salud de la Mujer. Rev Med Inst Mex Seguro Soc. 2006; 44 Supl 1: S3-21.

22. Benguigui Y. Prevención y control. Bases técnicas para la prevención, diagnóstico, tratamiento y control de las IRA en el primer nivel de atención. Infecciones respiratorias en niños. Washington, DC: OPS/OMS; 1997. p. 333-50.

23. Michelow IC, Olsen K, Lozano J, Rollins N, Duffy L, Ziegler T, et al. Epidemiology and clinical characteristics of community acquired pneumonia in hospitalized children. Pediatrics. 2004; 113: 701-7.

24. Gubert D, Moellering JR, Eliopoulos G, Sande M. The Sanford Guide to antimicrobial therapy 2005. 35th ed. USA: Vetesda; 2005. p. 25.

25. Miranda G, Solórzano F, Guiscafré H, Leaños B, Echaniz G, Carnalla MN, et al. Streptococcus pneumoniae: Low frequency of penicillin resistance and high resistance in trimethoprim-sulfamethoxazole in nasopharyngeal isolates from children in a rural area in Mexico. Arch Med Res. 1997; 28: 559-63.

26. Aspa J, Rajas O, de Castro FR. Pneumococcal antimicrobial resistance: therapeutic strategy and management in community-acquired pneumonia. Expert Opin Pharmacother. 2008; 9: 229-41.

27. Peterson LR. Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter? Clin Infect Dis. 2006; 42: 224-33.